| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |